$SEEL
Seelos Therapeutics Inc Stock $seel

$seel Overview Financials Valuation SEC Filings Company Website

2013 Q4 Form 10-Q Financial Statement

#000101749113000005 Filed on November 12, 2013

Income Statement

Concept	2013 Q4	2013 Q3	2012 Q3
Revenue	$362.0K	$28.00K	$4.895M
YoY Change	-84.78%	-99.43%	512.64%
Cost Of Revenue	$60.00K	$15.00K	$1.591M
YoY Change	-97.74%	-99.06%	8031.45%
Gross Profit	$299.0K	$13.00K	$3.304M
YoY Change	-210.33%	-99.61%	396.84%
Gross Profit Margin	82.6%	46.43%	67.5%
Selling, General & Admin	$3.110M	$2.870M	$4.438M
YoY Change	-38.17%	-35.33%	95.39%
% of Gross Profit	1040.13%	22076.92%	134.33%
Research & Development	$1.260M	$919.0K	$1.999M
YoY Change	7.69%	-54.03%	221.73%
% of Gross Profit	421.4%	7069.23%	60.5%
Depreciation & Amortization	$20.00K	$20.00K	$10.00K
YoY Change	-106.45%	100.0%	-88.89%
% of Gross Profit	6.69%	153.85%	0.3%
Operating Expenses	$4.370M	$3.176M	$5.629M
YoY Change	-29.4%	-43.58%	94.59%
Operating Profit	-$4.071M	-$3.163M	-$2.325M
YoY Change	-36.99%	36.04%	4.35%
Interest Expense	$2.490M	-$174.0K	-$73.00K
YoY Change		138.36%	-8.75%
% of Operating Profit
Other Income/Expense, Net	-$140.0K	-$36.00K	$42.00K
YoY Change	-46.15%	-185.71%	448.45%
Pretax Income	-$1.640M	-$3.200M	-$2.856M
YoY Change	-88.96%	12.04%	28.63%
Income Tax	$0.00	$0.00	-$362.0K
% Of Pretax Income
Net Earnings	-$1.345M	-$2.985M	-$2.494M
YoY Change	-93.15%	19.69%	12.34%
Net Earnings / Revenue	-371.55%	-10660.71%	-50.95%
Basic Earnings Per Share			-$0.12
Diluted Earnings Per Share	-$10.38M	-$21.36M	-$20.75M
COMMON SHARES
Basic Shares Outstanding	37.53M shares	36.98M shares	32.83M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2013 Q4	2013 Q3	2012 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$21.41M	$20.62M	$16.86M
YoY Change	41.51%	22.3%	89.86%
Cash & Equivalents	$21.41M	$20.62M	$16.86M
Short-Term Investments
Other Short-Term Assets	$460.0K	$670.0K	$5.640M
YoY Change	-91.0%	-88.12%	2156.0%
Inventory	$336.0K	$338.0K	$450.1K
Prepaid Expenses
Receivables	$59.00K	$35.00K	$3.807M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$22.26M	$21.66M	$26.75M
YoY Change	6.55%	-19.02%	186.09%
LONG-TERM ASSETS
Property, Plant & Equipment	$955.0K	$549.0K	$198.5K
YoY Change	58.9%	176.64%	-95.48%
Goodwill			$7.500M
YoY Change
Intangibles			$3.709M
YoY Change
Long-Term Investments
YoY Change
Other Assets	$91.00K	$90.00K	$1.311M
YoY Change	-9.0%	-93.13%	446.13%
Total Long-Term Assets	$1.046M	$639.0K	$14.00M
YoY Change	-64.95%	-95.44%	202.39%
TOTAL ASSETS
Total Short-Term Assets	$22.26M	$21.66M	$26.75M
Total Long-Term Assets	$1.046M	$639.0K	$14.00M
Total Assets	$23.31M	$22.30M	$40.75M
YoY Change	-2.38%	-45.27%	191.49%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$930.0K	$620.0K	$2.030M
YoY Change	-59.21%	-69.46%	33.55%
Accrued Expenses	$2.119M	$2.180M	$6.230M
YoY Change	-15.71%	-65.01%	510.83%
Deferred Revenue
YoY Change
Short-Term Debt	$2.600M	$1.440M	$4.000M
YoY Change		-64.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$11.76M	$8.400M	$14.78M
YoY Change	9.23%	-43.17%	411.41%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$1.100M	$0.00
YoY Change	-100.0%		-100.0%
Other Long-Term Liabilities	$578.0K	$127.0K	$212.9K
YoY Change	194.9%	-40.34%	-73.72%
Total Long-Term Liabilities	$578.0K	$127.0K	$212.9K
YoY Change	194.9%	-40.34%	-95.57%
TOTAL LIABILITIES
Total Short-Term Liabilities	$11.76M	$8.400M	$14.78M
Total Long-Term Liabilities	$578.0K	$127.0K	$212.9K
Total Liabilities	$12.34M	$10.35M	$17.21M
YoY Change	-28.51%	-39.84%	123.53%
SHAREHOLDERS EQUITY
Retained Earnings	-$268.1M	-$266.7M	-$231.5M
YoY Change	6.74%	15.22%
Common Stock	$279.0M	$278.7M	$255.0M
YoY Change	8.53%	9.28%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$10.97M	$11.95M	$23.54M
YoY Change
Total Liabilities & Shareholders Equity	$23.31M	$22.30M	$40.75M
YoY Change	-2.38%	-45.27%	191.49%

Cashflow Statement

Concept	2013 Q4	2013 Q3	2012 Q3
OPERATING ACTIVITIES
Net Income	-$1.345M	-$2.985M	-$2.494M
YoY Change	-93.15%	19.69%	12.34%
Depreciation, Depletion And Amortization	$20.00K	$20.00K	$10.00K
YoY Change	-106.45%	100.0%	-88.89%
Cash From Operating Activities	$1.130M	-$4.330M	-$2.900M
YoY Change	-141.39%	49.31%	3.94%
INVESTING ACTIVITIES
Capital Expenditures	-$450.0K	$0.00	-$430.0K
YoY Change	-4600.0%	-100.0%	2050.0%
Acquisitions
YoY Change
Other Investing Activities	$130.0K	$170.0K	$2.120M
YoY Change	-136.11%	-91.98%
Cash From Investing Activities	-$320.0K	$160.0K	$1.690M
YoY Change	-5.88%	-90.53%	-8550.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-30.00K	30.00K	10.00K
YoY Change	-102.44%	200.0%	-99.61%
NET CHANGE
Cash From Operating Activities	1.130M	-4.330M	-2.900M
Cash From Investing Activities	-320.0K	160.0K	1.690M
Cash From Financing Activities	-30.00K	30.00K	10.00K
Net Change In Cash	780.0K	-4.140M	-1.200M
YoY Change	-142.39%	245.0%	361.54%
FREE CASH FLOW
Cash From Operating Activities	$1.130M	-$4.330M	-$2.900M
Capital Expenditures	-$450.0K	$0.00	-$430.0K
Free Cash Flow	$1.580M	-$4.330M	-$2.470M
YoY Change	-157.66%	75.3%	-10.83%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2013Q3	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	615000	USD
CY2012Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	2277000	USD
CY2012Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	653000	USD
CY2013Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	35000	USD
	us-gaap	Accretion Expense AccretionExpense	0	USD
	us-gaap	Accretion Expense AccretionExpense	242000	USD
	us-gaap	Accretion Expense Including Asset Retirement Obligations AccretionExpenseIncludingAssetRetirementObligations	192000	USD
	us-gaap	Accretion Expense Including Asset Retirement Obligations AccretionExpenseIncludingAssetRetirementObligations	0	USD
CY2013Q3	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	780000	USD
CY2012Q4	us-gaap	Accrued Employee Benefits Current AccruedEmployeeBenefitsCurrent	2521000	USD
CY2012Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1841000	USD
CY2013Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	2180000	USD
CY2013Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	747000	USD
CY2012Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	286000	USD
CY2012Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	97000	USD
CY2013Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	152000	USD
CY2012Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	641000	USD
CY2013Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	0	USD
CY2013Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	278630000	USD
CY2012Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	257078000	USD
	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	700000	USD
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1622000	USD
CY2013Q3	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	100000	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	200000	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	400000	USD
CY2012Q3	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	100000	USD
CY2013Q3	us-gaap	Assets Assets	22301000	USD
CY2012Q4	us-gaap	Assets Assets	23880000	USD
CY2013Q3	us-gaap	Assets Current AssetsCurrent	21662000	USD
CY2012Q4	us-gaap	Assets Current AssetsCurrent	20896000	USD
CY2013Q3	us-gaap	Assets Held For Sale Current AssetsHeldForSaleCurrent	0	USD
CY2012Q4	us-gaap	Assets Held For Sale Current AssetsHeldForSaleCurrent	3654000	USD
CY2012Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation AssetsOfDisposalGroupIncludingDiscontinuedOperation	2765000	USD
CY2013Q3	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	0	USD
CY2012Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	825000	USD
CY2012Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Noncurrent AssetsOfDisposalGroupIncludingDiscontinuedOperationNoncurrent	1940000	USD
CY2013Q3	us-gaap	Assets Of Disposal Group Including Discontinued Operation Noncurrent AssetsOfDisposalGroupIncludingDiscontinuedOperationNoncurrent	0	USD
CY2012Q3	us-gaap	Business Acquisition Percentage Of Voting Interests Acquired BusinessAcquisitionPercentageOfVotingInterestsAcquired	1.00
CY2012Q4	us-gaap	Capital Leased Assets Gross CapitalLeasedAssetsGross	76000	USD
CY2013Q3	us-gaap	Capital Leased Assets Gross CapitalLeasedAssetsGross	76000	USD
CY2013Q3	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	134000	USD
CY2012Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	17000	USD
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	0	USD
	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	1855000	USD
CY2013Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	20619000	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	15130000	USD
CY2012Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	3413000	USD
CY2012Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	0	USD
CY2012Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	16861000	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7435000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	9426000	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	5489000	USD
	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	-1260000	USD
	us-gaap	Cash Provided By Used In Investing Activities Discontinued Operations CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations	1500000	USD
	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-1279000	USD
	us-gaap	Cash Provided By Used In Operating Activities Discontinued Operations CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations	-144000	USD
CY2012Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2013Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2013Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2012Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2013Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000	shares
CY2012Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	75000000	shares
CY2013Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	37533428	shares
CY2012Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	29937669	shares
CY2012Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	29937669	shares
CY2013Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	37533428	shares
CY2013Q3	us-gaap	Common Stock Value CommonStockValue	38000	USD
CY2012Q4	us-gaap	Common Stock Value CommonStockValue	30000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-12097000	USD
CY2013Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2985000	USD
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-15593000	USD
CY2012Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2457000	USD
CY2012Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	318000	USD
CY2013Q3	us-gaap	Construction In Progress Gross ConstructionInProgressGross	300000	USD
	us-gaap	Contracts Revenue ContractsRevenue	1480000	USD
CY2012Q3	us-gaap	Contracts Revenue ContractsRevenue	1269000	USD
	us-gaap	Contracts Revenue ContractsRevenue	1269000	USD
CY2013Q3	us-gaap	Contracts Revenue ContractsRevenue	28000	USD
CY2013Q3	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	1102000	USD
CY2012Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	3413000	USD
CY2013Q3	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	2543000	USD
CY2013Q3	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	1441000	USD
	us-gaap	Cost Of Services CostOfServices	1591000	USD
CY2012Q3	us-gaap	Cost Of Services CostOfServices	1591000	USD
	us-gaap	Cost Of Services CostOfServices	2568000	USD
CY2013Q3	us-gaap	Cost Of Services CostOfServices	15000	USD
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	1737000	USD
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	0	USD
	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	0	shares
	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	486923	shares
CY2012	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	0	USD
	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	1250000	USD
CY2012Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	4000000	USD
CY2013Q3	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	2750000	USD
CY2012Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	4000000	USD
CY2013Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	4000000	USD
CY2012Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	587000	USD
CY2013Q3	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	207000	USD
	us-gaap	Debtor Reorganization Items Write Off Of Deferred Financing Costs And Debt Discounts DebtorReorganizationItemsWriteOffOfDeferredFinancingCostsAndDebtDiscounts	200000	USD
CY2013Q3	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	0	USD
	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	641000	USD
	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	0	USD
CY2012Q3	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	0	USD
	us-gaap	Deferred Compensation Arrangement With Individual Compensation Expense DeferredCompensationArrangementWithIndividualCompensationExpense	68000	USD
	us-gaap	Deferred Compensation Arrangement With Individual Compensation Expense DeferredCompensationArrangementWithIndividualCompensationExpense	-165000	USD
CY2012Q4	us-gaap	Deferred Compensation Arrangement With Individual Recorded Liability DeferredCompensationArrangementWithIndividualRecordedLiability	2100000	USD
CY2013Q3	us-gaap	Deferred Compensation Arrangement With Individual Recorded Liability DeferredCompensationArrangementWithIndividualRecordedLiability	700000	USD
CY2013Q3	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	531000	USD
CY2012Q4	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	1529000	USD
CY2012Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	536000	USD
CY2013Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	45000	USD
	us-gaap	Depreciation Depreciation	60000	USD
CY2013Q3	us-gaap	Depreciation Depreciation	20000	USD
	us-gaap	Depreciation Depreciation	190000	USD
CY2012Q3	us-gaap	Depreciation Depreciation	10000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	57000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	510000	USD
CY2012Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	0	USD
CY2013Q3	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	292000	USD
CY2013Q3	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	194000	USD
CY2012Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	906000	USD
CY2012Q4	us-gaap	Disposal Group Including Discontinued Operation Accounts Payable DisposalGroupIncludingDiscontinuedOperationAccountsPayable	708000	USD
CY2012Q4	us-gaap	Disposal Group Including Discontinued Operation Accrued Liabilities DisposalGroupIncludingDiscontinuedOperationAccruedLiabilities	1087000	USD
CY2013Q3	us-gaap	Disposal Group Including Discontinued Operation Costs Of Goods Sold DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold	-23000	USD
CY2012Q3	us-gaap	Disposal Group Including Discontinued Operation Costs Of Goods Sold DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold	114000	USD
	us-gaap	Disposal Group Including Discontinued Operation Costs Of Goods Sold DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold	177000	USD
	us-gaap	Disposal Group Including Discontinued Operation Costs Of Goods Sold DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold	274000	USD
CY2012Q4	us-gaap	Disposal Group Including Discontinued Operation Deferred Revenue DisposalGroupIncludingDiscontinuedOperationDeferredRevenue	243000	USD
CY2012Q4	us-gaap	Disposal Group Including Discontinued Operation Intangible Assets Net DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNet	1877000	USD
CY2012Q4	us-gaap	Disposal Group Including Discontinued Operation Inventory DisposalGroupIncludingDiscontinuedOperationInventory	292000	USD
	us-gaap	Disposal Group Including Discontinued Operation Operating Expense DisposalGroupIncludingDiscontinuedOperationOperatingExpense	382000	USD
CY2012Q3	us-gaap	Disposal Group Including Discontinued Operation Operating Expense DisposalGroupIncludingDiscontinuedOperationOperatingExpense	913000	USD
CY2013Q3	us-gaap	Disposal Group Including Discontinued Operation Operating Expense DisposalGroupIncludingDiscontinuedOperationOperatingExpense	65000	USD
	us-gaap	Disposal Group Including Discontinued Operation Operating Expense DisposalGroupIncludingDiscontinuedOperationOperatingExpense	2407000	USD
CY2012Q4	us-gaap	Disposal Group Including Discontinued Operation Other Current Assets DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets	533000	USD
CY2012Q4	us-gaap	Disposal Group Including Discontinued Operation Other Current Liabilities DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities	3536000	USD
	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.38
CY2012Q4	us-gaap	Disposal Group Including Discontinued Operation Other Liabilities DisposalGroupIncludingDiscontinuedOperationOtherLiabilities	27000	USD
CY2012Q4	us-gaap	Disposal Group Including Discontinued Operation Other Noncurrent Assets DisposalGroupIncludingDiscontinuedOperationOtherNoncurrentAssets	23000	USD
CY2012Q4	us-gaap	Disposal Group Including Discontinued Operation Property Plant And Equipment Net DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNet	40000	USD
CY2012Q3	us-gaap	Disposal Group Including Discontinued Operation Revenue DisposalGroupIncludingDiscontinuedOperationRevenue	257000	USD
	us-gaap	Disposal Group Including Discontinued Operation Revenue DisposalGroupIncludingDiscontinuedOperationRevenue	484000	USD
	us-gaap	Disposal Group Including Discontinued Operation Revenue DisposalGroupIncludingDiscontinuedOperationRevenue	432000	USD
CY2013Q3	us-gaap	Disposal Group Including Discontinued Operation Revenue DisposalGroupIncludingDiscontinuedOperationRevenue	58000	USD
CY2013Q1	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal DisposalGroupNotDiscontinuedOperationGainLossOnDisposal	-1400000	USD
CY2013Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.08
CY2012Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.09
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.46
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.47
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	0	USD
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	127000	USD
CY2013Q3	us-gaap	Escrow Deposit EscrowDeposit	200000	USD
CY2013Q3	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	36000	USD
CY2012Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	31000	USD
CY2012Q3	us-gaap	Gain Loss On Contract Termination GainLossOnContractTermination	0	USD
CY2013Q3	us-gaap	Gain Loss On Contract Termination GainLossOnContractTermination	534000	USD
	us-gaap	Gain Loss On Contract Termination GainLossOnContractTermination	534000	USD
	us-gaap	Gain Loss On Contract Termination GainLossOnContractTermination	0	USD
	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	-1231000	USD
	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	0	USD
CY2012Q3	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	0	USD
CY2013Q3	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	198000	USD
CY2012Q3	us-gaap	Gain Loss On Sale Of Stock In Subsidiary Or Equity Method Investee GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee	125000	USD
CY2013Q3	us-gaap	Gain Loss On Sale Of Stock In Subsidiary Or Equity Method Investee GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee	75000	USD
	us-gaap	Gain Loss On Sale Of Stock In Subsidiary Or Equity Method Investee GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee	125000	USD
	us-gaap	Gain Loss On Sale Of Stock In Subsidiary Or Equity Method Investee GainLossOnSaleOfStockInSubsidiaryOrEquityMethodInvestee	180000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10446000	USD
CY2012Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3755000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	10309000	USD
CY2013Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2866000	USD
CY2013Q3	us-gaap	Gross Profit GrossProfit	13000	USD
CY2012Q3	us-gaap	Gross Profit GrossProfit	3304000	USD
	us-gaap	Gross Profit GrossProfit	-419000	USD
	us-gaap	Gross Profit GrossProfit	3977000	USD
CY2012Q4	us-gaap	Impairment Of Long Lived Assets To Be Disposed Of ImpairmentOfLongLivedAssetsToBeDisposedOf	500000	USD
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-9941000	USD
CY2012Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-1921000	USD
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-14235000	USD
CY2013Q3	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-3199000	USD
CY2012Q3	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-2283000	USD
CY2013Q3	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-3199000	USD
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-10303000	USD
	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	-14235000	USD
CY2013Q3	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.09
	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.43
CY2012Q3	us-gaap	Income Loss From Continuing Operations Per Basic And Diluted Share IncomeLossFromContinuingOperationsPerBasicAndDilutedShare	-0.07
	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-1358000	USD
	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-2193000	USD
CY2013Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	214000	USD
CY2012Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax IncomeLossFromDiscontinuedOperationsNetOfTax	-573000	USD
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare	-0.08
CY2012Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare	-0.02
CY2013Q3	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare	0.01
	us-gaap	Income Loss From Discontinued Operations Net Of Tax Per Basic And Diluted Share IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare	-0.04
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2012Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-362000	USD
CY2013Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-362000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1502000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	279000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-276000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2491000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-39000	USD
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	562000	USD
	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	0	USD
	us-gaap	Increase Decrease In Accrued Salaries IncreaseDecreaseInAccruedSalaries	-917000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-248000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	225000	USD
	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	0	USD
	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	243000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	109000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	338000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-21000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	171000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	63000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	926000	USD
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	280000	USD
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	0	USD
CY2012Q3	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-73000	USD
CY2013Q3	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-174000	USD
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-215000	USD
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-618000	USD
	us-gaap	Interest Paid InterestPaid	189000	USD
	us-gaap	Interest Paid InterestPaid	223000	USD
CY2013Q3	us-gaap	Inventory Gross InventoryGross	300000	USD
CY2012Q4	us-gaap	Inventory Gross InventoryGross	0	USD
CY2012Q3	us-gaap	Inventory Gross InventoryGross	0	USD
CY2012Q4	us-gaap	Inventory Net InventoryNet	0	USD
CY2013Q3	us-gaap	Inventory Net InventoryNet	338000	USD
CY2013Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	200000	USD
CY2012Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	0	USD
CY2013Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	100000	USD
CY2012Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	0	USD
CY2012Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	130000	USD
CY2013Q3	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	20000	USD
CY2013Q3	us-gaap	Licenses Revenue LicensesRevenue	0	USD
CY2013Q3	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	135000	USD
CY2012Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	126000	USD
CY2013Q3	us-gaap	Liabilities Liabilities	10354000	USD
CY2012Q4	us-gaap	Liabilities Liabilities	17259000	USD
CY2012Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	23880000	USD
CY2013Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	22301000	USD
CY2012Q4	us-gaap	Liabilities Current LiabilitiesCurrent	10768000	USD
CY2013Q3	us-gaap	Liabilities Current LiabilitiesCurrent	8400000	USD
CY2012Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation	3983000	USD
CY2012Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	3536000	USD
CY2013Q3	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Current LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent	0	USD
CY2012Q4	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Noncurrent LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent	447000	USD
CY2013Q3	us-gaap	Liabilities Of Disposal Group Including Discontinued Operation Noncurrent LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent	0	USD
CY2012Q3	us-gaap	Licenses Revenue LicensesRevenue	3626000	USD
	us-gaap	Licenses Revenue LicensesRevenue	4299000	USD
	us-gaap	Licenses Revenue LicensesRevenue	669000	USD
	us-gaap	Net Cash Provided By Used In Discontinued Operations NetCashProvidedByUsedInDiscontinuedOperations	1356000	USD
	us-gaap	Net Cash Provided By Used In Discontinued Operations NetCashProvidedByUsedInDiscontinuedOperations	-2539000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	16658000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	19536000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	2670000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	3528000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-16053000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-10368000	USD
CY2012Q3	us-gaap	Net Income Loss NetIncomeLoss	-2494000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-15593000	USD
	us-gaap	Net Income Loss NetIncomeLoss	-12134000	USD
CY2013Q3	us-gaap	Net Income Loss NetIncomeLoss	-2985000	USD
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-641000	USD
CY2013Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-36000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-858000	USD
CY2012Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	42000	USD
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	113000	USD
CY2013Q3	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	Segment
	us-gaap	Operating Expenses OperatingExpenses	14393000	USD
	us-gaap	Operating Expenses OperatingExpenses	12958000	USD
CY2013Q3	us-gaap	Operating Expenses OperatingExpenses	3176000	USD
CY2012Q3	us-gaap	Operating Expenses OperatingExpenses	5629000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-13377000	USD
CY2013Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-3163000	USD
CY2012Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2325000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-10416000	USD
CY2012Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	244000	USD
CY2013Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	695000	USD
CY2013Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	90000	USD
CY2012Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	100000	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	37000	USD
CY2013Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	0	USD
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	0	USD
CY2012Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	37000	USD
CY2012Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	57000	USD
CY2013Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	201000	USD
CY2012Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	196000	USD
CY2013Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	127000	USD
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	2000	USD
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-17000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-12000	USD
CY2012Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	0	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-331000	USD
CY2013Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	138000	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	0	USD
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-270000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	-836000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	0	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	119000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	23000	USD
CY2013Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2012Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2013Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2012Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2013Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2012Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2013Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	338000	USD
CY2012Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	582000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	16612000	USD
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	19489000	USD
	us-gaap	Proceeds From Sale Of Buildings ProceedsFromSaleOfBuildings	4100000	USD
CY2013Q1	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	3600000	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	2000	USD
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	3657000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	10000	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	40000	USD
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	46000	USD
CY2012Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	698000	USD
CY2013Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	701000	USD
CY2012Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	601000	USD
CY2013Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	549000	USD
CY2013Q3	us-gaap	Rental Income Nonoperating RentalIncomeNonoperating	0	USD
CY2012Q3	us-gaap	Rental Income Nonoperating RentalIncomeNonoperating	115000	USD
	us-gaap	Rental Income Nonoperating RentalIncomeNonoperating	340000	USD
	us-gaap	Rental Income Nonoperating RentalIncomeNonoperating	91000	USD
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	0	USD
	us-gaap	Repayments Of Long Term Capital Lease Obligations RepaymentsOfLongTermCapitalLeaseObligations	3000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3867000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4209000	USD
CY2013Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	919000	USD
CY2012Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1999000	USD
CY2012Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	52000	USD
CY2013Q3	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	332000	USD
CY2012Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	343000	USD
CY2013Q3	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	0	USD
CY2013Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-266721000	USD
CY2012Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-251128000	USD
CY2013Q3	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	0	USD
CY2012Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	359000	USD
CY2013Q3	us-gaap	Sales Revenue Net SalesRevenueNet	28000	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	2149000	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	5568000	USD
CY2012Q3	us-gaap	Sales Revenue Net SalesRevenueNet	4895000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	1722000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	1622000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	20000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures	0	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	3000000	shares
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	3205492	shares
CY2013Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	6185492	shares
CY2013Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	6800000	shares
CY2013Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	3000000	shares
CY2013Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1027577	shares
CY2013Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	4.07
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	834752	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	1253771	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.55
CY2013Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	11525000	USD
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	USD
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2213916	shares
CY2013Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2632935	shares
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.71
CY2013Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.19
CY2013Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	11218000	USD
CY2013Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	2562899	shares
CY2013Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	3.19
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.00
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	3.48
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.46
CY2013Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	3275000	USD
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y10M24D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y6M
CY2012	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y10M24D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P7Y6M
	us-gaap	Stock Issued During Period Shares Conversion Of Convertible Securities StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities	486923	shares
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	1543000	USD
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	1737000	USD
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	792000	USD
CY2013Q3	us-gaap	Stockholders Equity StockholdersEquity	11947000	USD
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	6621000	USD
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:12px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-top:12px;text-align:justify;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of these consolidated financial statements requires the Company to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. The Company’s most significant estimates relate to the estimated fair value of future contingent consideration related to the acquisition of TopoTarget USA, Inc. and other acquisition or disposition related activities, whether revenue recognition criteria have been met, estimated costs to complete under its research contracts, the fair value of its embedded derivatives related to the convertible notes payable, and valuation allowances for the Company’s deferred tax benefit. The Company’s actual results may differ from these estimates under different assumptions or conditions.</font></div></div>
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	33360710	shares
CY2012Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	29258434	shares
CY2013Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	37003853	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	26652258	shares
CY2012Q4	apri	Accrued Consulting Fees Current AccruedConsultingFeesCurrent	388000	USD
CY2013Q3	apri	Accrued Consulting Fees Current AccruedConsultingFeesCurrent	67000	USD
CY2012Q1	apri	Class Of Warrant Term ClassOfWarrantTerm	P5Y
CY2013Q2	apri	Class Of Warrant Term ClassOfWarrantTerm	P5Y
CY2012Q4	apri	Contractual Sales Price For Divestiture Of Business ContractualSalesPriceForDivestitureOfBusiness	4100000	USD
CY2013Q3	apri	Convertible Notes Current Unamortized Discount ConvertibleNotesCurrentUnamortizedDiscount	59000	USD
CY2012Q4	apri	Convertible Notes Current Unamortized Discount ConvertibleNotesCurrentUnamortizedDiscount	59000	USD
CY2013Q3	apri	Convertible Notes Noncurrent Unamortized Discount ConvertibleNotesNoncurrentUnamortizedDiscount	148000	USD
CY2012Q4	apri	Convertible Notes Noncurrent Unamortized Discount ConvertibleNotesNoncurrentUnamortizedDiscount	587000	USD
CY2012Q4	apri	Disposal Group Including Discontinued Operation Contingent Consideration Current DisposalGroupIncludingDiscontinuedOperationContingentConsiderationCurrent	1328000	USD
CY2012Q4	apri	Disposal Group Including Discontinued Operation Contingent Consideration Noncurrent DisposalGroupIncludingDiscontinuedOperationContingentConsiderationNoncurrent	420000	USD
CY2012Q3	apri	Disposal Group Including Discontinued Operation Nonoperating Income Expense DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense	197000	USD
	apri	Disposal Group Including Discontinued Operation Nonoperating Income Expense DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense	4000	USD
CY2013Q3	apri	Disposal Group Including Discontinued Operation Nonoperating Income Expense DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense	0	USD
	apri	Disposal Group Including Discontinued Operation Nonoperating Income Expense DisposalGroupIncludingDiscontinuedOperationNonoperatingIncomeExpense	0	USD
CY2012Q4	apri	Disposal Group Including Discontinued Operation Product Warranty Accrual Classified Current DisposalGroupIncludingDiscontinuedOperationProductWarrantyAccrualClassifiedCurrent	170000	USD
	apri	Increase Decreasein Deferred Rental Incomeand Other Noncurrent Assets IncreaseDecreaseinDeferredRentalIncomeandOtherNoncurrentAssets	-1000	USD
	apri	Increase Decreasein Deferred Rental Incomeand Other Noncurrent Assets IncreaseDecreaseinDeferredRentalIncomeandOtherNoncurrentAssets	436000	USD
	apri	Issuance Of Common Stock And Warrants Value IssuanceOfCommonStockAndWarrantsValue	15820000	USD
CY2012Q4	apri	Long Lived Assets Held For Sale Estimated Selling Cost LongLivedAssetsHeldForSaleEstimatedSellingCost	500000	USD
	apri	Receivablefrom Buyer Upon Divestitureof Business ReceivablefromBuyerUponDivestitureofBusiness	51000	USD
	apri	Receivablefrom Buyer Upon Divestitureof Business ReceivablefromBuyerUponDivestitureofBusiness	0	USD
CY2012Q4	apri	Research And Development Accrued Expense ResearchAndDevelopmentAccruedExpense	564000	USD
CY2013Q3	apri	Research And Development Accrued Expense ResearchAndDevelopmentAccruedExpense	671000	USD
	apri	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercisable Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisableWeightedAverageRemainingContractualTerm	P3Y9M18D
	apri	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Term One ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTermOne	P3Y9M18D
CY2013Q3	apri	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber	6185492	shares
CY2013Q3	apri	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice	4.01
	apri	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisesInPeriodWeightedAverageExercisePrice	2.27
	apri	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice	3.40
CY2013Q3	apri	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice	4.01
CY2012Q4	apri	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice	4.56
	apri	Share Based Compensation Arrangement By Share Based Payment Award Non Options Equity Instruments Forfeited Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsEquityInstrumentsForfeitedWeightedAverageExercisePrice	0.00
CY2012	apri	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms1 SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms1	P3Y9M18D
CY2012Q4	apri	Short Term Liability Arising From Deconsolidation Of French Subsidiaries ShortTermLiabilityArisingFromDeconsolidationOfFrenchSubsidiaries	0	USD
CY2013Q3	apri	Short Term Liability Arising From Deconsolidation Of French Subsidiaries ShortTermLiabilityArisingFromDeconsolidationOfFrenchSubsidiaries	2846000	USD
	apri	Stock Issued During Period Value Stock Warrants Exercised StockIssuedDuringPeriodValueStockWarrantsExercised	46000	USD
CY2012Q1	apri	Warrants Aggregate Grant Date Fair Value WarrantsAggregateGrantDateFairValue	3700000	USD
CY2013Q2	apri	Warrants Aggregate Grant Date Fair Value WarrantsAggregateGrantDateFairValue	3300000	USD
CY2013Q2	apri	Warrants Expected Volatility WarrantsExpectedVolatility	0.70
CY2012Q1	apri	Warrants Expected Volatility WarrantsExpectedVolatility	0.700
CY2012Q1	apri	Warrants Risk Free Interest Rate WarrantsRiskFreeInterestRate	0.010
CY2013Q2	apri	Warrants Risk Free Interest Rate WarrantsRiskFreeInterestRate	0.010
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2013
	dei	Document Period End Date DocumentPeriodEndDate	2013-09-30
	dei	Document Type DocumentType	10-Q
	dei	Entity Central Index Key EntityCentralIndexKey	0001017491
CY2013Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	37533428	shares
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Entity Registrant Name EntityRegistrantName	APRICUS BIOSCIENCES, INC.
	dei	Trading Symbol TradingSymbol	APRI

Files In Submission

Name	View Source	Status
0001017491-13-000005-index-headers.html	Edgar Link	pending
0001017491-13-000005-index.html	Edgar Link	pending
0001017491-13-000005.txt	Edgar Link	pending
0001017491-13-000005-xbrl.zip	Edgar Link	pending
apri-20130930.xml	Edgar Link	completed
apri-20130930.xsd	Edgar Link	pending
apri-20130930_cal.xml	Edgar Link	unprocessable
apri-20130930_def.xml	Edgar Link	unprocessable
apri-20130930_lab.xml	Edgar Link	unprocessable
apri-20130930_pre.xml	Edgar Link	unprocessable
apri-2013930x10q.htm	Edgar Link	pending
apri-2013930xex311.htm	Edgar Link	pending
apri-2013930xex312.htm	Edgar Link	pending
apri-2013930xex321.htm	Edgar Link	pending
apri-2013930xex322.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SEEL
Seelos Therapeutics Inc Stock $seel

2013 Q4 Form 10-Q Financial Statement

#000101749113000005 Filed on November 12, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SEEL Seelos Therapeutics Inc Stock $seel

2013 Q4 Form 10-Q Financial Statement

#000101749113000005 Filed on November 12, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SEEL
Seelos Therapeutics Inc Stock $seel